A Phase 2 Trial of SCO-101 in Combination With FOLFIRI for Patients With Metastatic Colorectal Cancer (mCRC) With Acquired Resistance to FOLFIRI
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Metastatic Colorectal Cancer
Related studies linked through entity extraction aliases.
QL1203 In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy and Safety
- Status
- UNKNOWN
- Phase
- PHASE3
Early Detection of Relapses in Stage IV Colorectal Cancer Patients
- Status
- UNKNOWN
- Phase
- N/A
The Gene Profiles of Primary and Heterogeneous Metastases of Colorectal Cancer
- Status
- UNKNOWN
- Phase
- N/A
Re-challenge of Anti-EGFR for Patients With RAS/BRAF Wild-type Metastatic CRC
- Status
- COMPLETED
- Phase
- PHASE2
Sintilimab (IBI308) Combined With Bevacizumab + XELOX Regimen in Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Randomized Phase III Study Comparing Maintenance Treatment With Fluoropyrimidine + Bevacizumab Versus Fluoropyrimidine After Induction Chemotherapy for a Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE3
LONsurf and G-CSF Use: Being On A Right Dose-intensity to Optimize Treatment Efficacy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
VB-111 in Combination With Nivolumab in People With Metastatic Colorectal Cancer (mCRC)
- Status
- TERMINATED
- Phase
- PHASE2
Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Modelle 001, TS-inhibition in Colorectal Liver Metastases Comparing Arfolitixorin and Calciumfolinate
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Immunotherapy With Y90-RadioEmbolization for Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1
CAPOXIRI+Bevacizumab vs. FOLFOXIRI+Bevacizumab for mCRC
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Rivoceranib and Trifluridine/Tipiracil for Metastatic Colorectal Cancer (mCRC)
- Status
- TERMINATED
- Phase
- PHASE1
Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
FOLFOXIRI Plus Cetuximab vs. FOLFOXIRI Plus Bevacizumab 1st-line in BRAF-mutated mCRC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Metastatic Colorectal Cancer Database
- Status
- UNKNOWN
- Phase
- N/A
Regorafenib and XELOX as 2nd Line Treatment in Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator's Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Basket Trial for Combination Therapy With Durvalumab (Anti-PDL1) (MEDI4736) and Tremelimumab (Anti-CTLA4) in Patients With Metastatic Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE2